Find uplifting stories about heroes, innovations, and solutions
9001 results for "cancer survival"
Seven in ten Americans now survive cancer for at least five years after diagnosis, according to the American Cancer Society's latest report. This milestone represents a stunning turnaround from the mid-1970s, when only half of patients reached that mark.
%3Aquality(70)%3Afocal(396x236%3A406x246)%2Fcloudfront-us-east-1.images.arcpublishing.com%2Fshawmedia%2FSNIB6CDRAQBKJOAOCNSS64H7U4.jpg)
For the first time ever, the American Cancer Society reports improved five-year survival rates across every type of cancer. This breakthrough means more people are living longer after diagnosis than at any point in history.
Seven in ten cancer patients now survive at least five years after diagnosis, a stunning achievement that reflects two decades of medical innovation. Survival rates have jumped across nearly every cancer type, turning once-grim diagnoses into real fighting chances.
For the first time ever, 70% of Americans diagnosed with cancer are surviving five years or longer. The historic milestone comes from decades of progress in prevention, early detection, and breakthrough treatments.
For the first time in history, 70% of cancer patients are surviving their diagnosis, marking a stunning achievement in modern medicine. From Hollywood stars to everyday heroes, survivors are not just beating cancer but thriving in remarkable new chapters of their lives.
A breakthrough treatment for pancreatic cancer shows promise in doubling how long patients survive with one of the deadliest forms of cancer. This medical advance offers new hope for thousands of families facing this devastating diagnosis.
A groundbreaking vaccine targeting a common mutation in deadly brain tumors helped two-thirds of patients survive eight years in a clinical trial. The treatment trains the immune system to hunt down cancer cells carrying the genetic error found in most gliomas. ##
For the first time ever, 70% of Americans are living at least five years after a cancer diagnosis, marking a dramatic shift from the 1970s when survival rates were below 50%. The American Cancer Society says this progress means transforming care to support millions living full lives after treatment.
Seven in 10 Americans diagnosed with cancer now survive at least five years, up from just five in 10 during the mid-1970s. The American Cancer Society says prevention, early detection, and better treatments are saving more lives than ever.
Scientists at UCLA have achieved breakthrough results in treating advanced colorectal cancer, with a new combination therapy doubling two-year survival rates. The research team is also making major strides in prevention, from mailing free screening kits to developing powerful cancer vaccines.
A new pill targeting the KRAS mutation doubles survival time in pancreatic cancer patients, marking the biggest treatment breakthrough ever for one of the world's deadliest cancers. After 25 years of research and $17 million in funding, scientists are finally seeing progress on multiple fronts at once.
A groundbreaking immunotherapy treatment given before surgery is helping liver cancer patients beat the odds, with 60% surviving four years or more. Researchers in Taiwan discovered that priming the immune system before removing tumors creates a lasting defense against one of the deadliest cancers.
More children are beating cancer than ever before, with survival rates climbing to 85% in the United States. This milestone reflects decades of research breakthroughs and improved treatments that are giving young patients a fighting chance.
A breakthrough drug called daraxonrasib has shown it can extend survival in pancreatic cancer patients, one of medicine's toughest challenges. The announcement from Revolution Medicines marks what experts are calling a new era in treating this devastating disease.
Seven in 10 Americans now survive cancer five years after diagnosis, up from just half in the mid-1970s. Decades of research breakthroughs and better screening have prevented 4.8 million deaths since 1991.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, doubled survival rates in early trials and kept one patient cancer-free for nearly five years. The vaccine trains each patient's immune system to recognize up to 40 unique cancer proteins, making it harder for tumors to hide.
Cancer survival rates have increased for nearly every cancer type over the past 20 years, and volunteers participating in clinical trials are the unsung heroes making it happen. These brave patients are testing tomorrow's treatments today, giving hope to millions facing a cancer diagnosis.
A breakthrough drug called daraxonrasib doubled survival time for pancreatic cancer patients compared to chemotherapy, offering new hope for one of the deadliest cancers. The treatment targets the genetic mutation behind 90% of pancreatic cancers and causes far fewer severe side effects.
A personalized mRNA vaccine is helping pancreatic cancer patients survive six years and counting, with nearly 90% of responders still alive. For a disease with just 13% five-year survival, this breakthrough offers real hope.
A new once-daily pill for pancreatic cancer nearly doubled patient survival in a groundbreaking late-stage study. The experimental drug offers fresh hope for one of the deadliest forms of cancer.
Showing 20 of 9001